Ohcanbohtosat - Kimiharu Uozumi
- Čájehuvvo 1 - 6 / 6
-
1
Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+ T Cell in Adult T Cell Leukemia Patients Dahkki Tomohiro Kozako, Naomichi Arima, Shingo Toji, Izumi Masamoto, Masaki Akimoto, Heiichiro Hamada, Xiaofang Che, Hiroshi Fujiwara, Kakushi Matsushita, Masahito Tokunaga, Koichi Haraguchi, Kimiharu Uozumi, Susumu Suzuki, Toshiro Takezaki, Shunro Sonoda
Almmustuhtton 2006Artigo -
2
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF- B, as a strategy for chemoprevention and therapy of adult... Dahkki Mariko Watanabe, Takeo Ohsugi, Momoko Shoda, Takaomi Ishida, Shigemi Aizawa, Masae Maruyama-Nagai, Atae Utsunomiya, Shin Koga, Yasuaki Yamada, Shimeru Kamihira, Akihiko Okayama, Hiroshi Kikuchi, Kimiharu Uozumi, Kazunari Yamaguchi, Masaaki Higashihara, Kazuo Umezawa, Toshiki Watanabe, Ryouichi Horie
Almmustuhtton 2005Artigo -
3
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan Dahkki Masako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, Akihiko Okayama, Kaoru Uchimaru, Ki‐Ryang Koh, Masao Ogata, Hiroshi Kikuchi, Yasuko Sagara, Kimiharu Uozumi, Manabu Mochizuki, Kunihiro Tsukasaki, Yoshio Saburi, Masaomi Yamamura, Junji Tanaka, Yukiyoshi Moriuchi, Shigeo Hino, Shimeru Kamihira, Kazunari Yamaguchi
Almmustuhtton 2010Artigo -
4
Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma Dahkki Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai, Kunihiro Tsukasaki, Naokuni Uike, Kimiharu Uozumi, Kazunari Yamaguchi, Yasuaki Yamada, Shuichi Hanada, Kazuo Tamura, Shigeo Nakamura, Hiroshi Inagaki, Koichi Ohshima, Hitoshi Kiyoi, Takashi Ishida, Kouji Matsushima, Shiro Akinaga, Michinori Ogura, Masao Tomonaga, Ryuzo Ueda
Almmustuhtton 2010Artigo -
5
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase <scp>II</scp> study Dahkki Takashi Ishida, Tatsuro Jo, Shigeki Takemoto, Hitoshi Suzushima, Kimiharu Uozumi, Kazuhito Yamamoto, Naokuni Uike, Yoshio Saburi, Kisato Nosaka, Atae Utsunomiya, Kensei Tobinai, Hiroshi Fujiwara, Kenji Ishitsuka, Shinichiro Yoshida, Naoya Taira, Yukiyoshi Moriuchi, Kazunori Imada, Toshihiro Miyamoto, Shiro Akinaga, Masao Tomonaga, Ryuzo Ueda
Almmustuhtton 2015Artigo -
6
Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A) Dahkki Takuya Fukushima, Shogo Nomura, M Shimoyama, Taro Shibata, Yoshitaka Imaizumi, Yoshiyuki Moriuchi, Takeaki Tomoyose, Kimiharu Uozumi, Yukio Kobayashi, Noriyasu Fukushima, Atae Utsunomiya, Mitsutoshi Tara, Kisato Nosaka, Michihiro Hidaka, Naokuni Uike, Shinichiro Yoshida, Kazuo Tamura, Kenji Ishitsuka, Mitsutoshi Kurosawa, Masanobu Nakata, Haruhiko Fukuda, Tomomitsu Hotta, Kensei Tobinai, Kunihiro Tsukasaki
Almmustuhtton 2014Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Biochemistry
Biology
Immunology
Leukemia
T-cell leukemia
Virology
Chemotherapy
Clinical trial
Gastroenterology
Human T-lymphotropic virus 1
In vitro
Lymphoma
Rash
Adverse effect
Antigen
Apoptosis
Asymptomatic
Asymptomatic carrier
CD8
CTL*
Cancer research
Clinical endpoint
Cohort
Confidence interval
Cytotoxic T cell
Diffuse large B-cell lymphoma
Epitope
Febrile neutropenia